The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
批准号:
10616939
负责人:
Daniel S Perrien
金额:
$11.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-06-30
关键词:
ACVR1 geneAddressAgonistAnti-Inflammatory AgentsApoptosisApoptoticBiological AssayBone Morphogenetic ProteinsCellsCessation of lifeChemicalsChondrocytesChondrogenesisCoculture TechniquesDataDevelopmentDiseaseFeedbackFibrosisFlareFunctional disorderGrowthHeterotopic OssificationImmobilizationImmuneIn VitroIndividualInflammationInflammatoryInjuryIntramuscularJointsLeadLesionLinkMAP Kinase GeneMediatingMusMuscleMutationMyelogenousMyeloid CellsNatural ImmunityOsteogenesisPainPatientsPoint MutationRare DiseasesResistanceRoleSTING agonistsSignal PathwaySignal TransductionSignaling ProteinSkeletal MuscleSourceSwellingSystemic infectionTNF geneTimeTissuesTransforming Growth Factor betaactivin Abone morphogenetic protein receptor type Icytokineearly childhoodedg-1 Proteingenetic approachinhibitorinjuredinsightinterstitialmacrophagemonocytemuscle regenerationmutantnanoparticlenew therapeutic targetp38 Mitogen Activated Protein Kinaseprematurepreventprogenitorprogressive myositis ossificansreceptorrepairedresponsetissue repairtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fibrodysplasia ossificans progressiva (FOP) is a rare, currently untreatable, congenital disease in which
skeletal muscle repair is redirected to endochondral bone formation (heterotopic ossification, HO) causing
pain, muscle destruction, and joint fusion, leading to progressive immobilization and eventually premature
death. FOP is caused by a mutation in Alk2 (most commonly R206H) that renders the receptor sensitive to
aberrant activation by Activin A (ActA). However, the “flares” that lead to HO appear to be initiated by
inflammatory insults, and HO can be reduced in FOP mice by depletion of inflammatory innate immune cells
including macrophages. Fibroadipoprogenitors (FAPs), residing in the muscle interstitium appear to be the
critical precursors of chondrocytes in FOP. However, in healthy muscle repair, macrophages secrete TNFα at
a critical time to trigger apoptosis of FAPs. The fact that FAPs survive and differentiate into chondrocytes
suggests their interaction with macrophages is disrupted in FOP. Therefore, this proposal will explore the
hypothesis that pro-inflammatory M1-like and anti-inflammatory M2-like macrophages are critical sources of
cytokines that enable survival and expansion of the chondrogenic fibroadipoprogenitors in FOP. Specifically,
it seeks to determine whether macrophages are a critical source of ActA and what signals pathways in FAPS
are disrupted to block their normal apoptotic fate. These studies will be the first to explore the mechanisms by
which macrophages interact with chondrogenic FAPs to support chondrogenesis and HO, and they will provide
critical insights to the early stages of FOP flares.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10434101
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10249238
-
项目类别:
-
资助金额:$42.39万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10150273
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10168215
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10407678
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva
-
批准号:8871583
-
项目类别:
-
资助金额:$20.72万
-
财政年份:2015
-
负责人:Daniel S Perrien
-
依托单位:
vivaCT80 - in vivo small animal microCT
-
批准号:8639867
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2014
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8774183
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8667309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8442139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Novel ultrahigh resolution microCT imaging system
-
批准号:7794779
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2010
-
负责人:Daniel S Perrien
-
依托单位:
海外基金